High materiality7/10
Elevance Health price target raised to $469 from $457 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raised ELV target to 469 from 457; price 400.09; priceChangeSinceSignal 3.15; bullish setup.
- ELV: target 469; price 400.09; +3.15%
Key facts
- 01
Target: $469
- 02
Posted price: $400.09
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.